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ABSTRACT
Endogenous retroviruses (ERVs) are the remnants of ancient retroviral infections of germ cells. Previous work identified one of
the youngest feline ERV groups, ERV-DC, and reported that two ERV-DC loci, ERV-DC10 and ERV-DC18 (ERV-DC10/DC18),
can replicate in cultured cells. Here, we identified another replication-competent provirus, ERV-DC14, on chromosome C1q32.
ERV-DC14 differs from ERV-DC10/DC18 in its phylogeny, receptor usage, and, most notably, transcriptional activities; al-
though ERV-DC14 can replicate in cultured cells, it cannot establish a persistent infection owing to its low transcriptional activ-
ity. Furthermore, we examined ERV-DC transcription and its regulation in feline tissues. Quantitative reverse transcription-
PCR (RT-PCR) detected extremely low ERV-DC10 expression levels in feline tissues, and bisulfite sequencing showed that 5=
long terminal repeats (LTRs) of ERV-DC10/DC18 are significantly hypermethylated in feline blood cells. Reporter assays found
that the 5=-LTR promoter activities of ERV-DC10/DC18 are high, whereas that of ERV-DC14 is low. This difference in promoter
activity is due to a single substitution from A to T in the LTR, and reverse mutation at this nucleotide in ERV-DC14 enhanced its
replication and enabled it to persistently infect cultured cells. Therefore, ERV-DC LTRs can be divided into two types based on
this nucleotide, the A type or T type, which have strong or attenuated promoter activity, respectively. Notably, ERV-DCs with
T-type LTRs, such as ERV-DC14, have expanded in the cat genome significantly more than A-type ERV-DCs, despite their low
promoter activities. Our results provide insights into how the host controls potentially infectious ERVs and, conversely, how
ERVs adapt to and invade the host genome.
IMPORTANCE
The domestic cat genome contains many endogenous retroviruses, including ERV-DCs. These ERV-DCs have been acquired
through germ cell infections with exogenous retroviruses. Some of these ERV-DCs are still capable of producing infectious viri-
ons. Hosts must tightly control these ERVs because replication-competent viruses in the genome pose a risk to the host. Here, we
investigated how ERV-DCs are adapted by their hosts. Replication-competent viruses with strong promoter activity, such as
ERV-DC10 and ERV-DC18, were suppressed by promoter methylation in LTRs. On the other hand, replication-competent vi-
ruses with weak promoter activity, such as ERV-DC14, seemed to escape strict control via promoter methylation by the host.
Interestingly, ERV-DCs with weak promoter activity, such as ERV-DC14, have expanded in the cat genome significantly more
than ERV-DCs with strong promoter activity. Our results improve the understanding of the host-virus conflict and how ERVs
adapt in their hosts over time.
Endogenous retroviruses (ERVs) are resident DNA copies thatabound in host chromosomal DNA and compromise 8 to
10% of human and mouse genomes (1, 2). They have been found
in all vertebrates, including mammals, fish, birds, reptiles, and
amphibians (3). ERVs were originally acquired through germ cell
infections with exogenous retroviruses of ancestral host lineages
and have thereafter been transmitted vertically from parent to
offspring according to Mendelian inheritance patterns (4, 5).
Consequently, mammalian genomes are littered with the signa-
tures of ancient retroviral infections. Most ERVs have already
been inactivated by accumulated mutations that disrupt viral
genes or regulatory sequences.
Although most ERVs are inactivated, a few ERVs that still re-
tain potential replication capacities have been observed in several
animals (6), including mice (7), koalas (8, 9), pigs (10–14), and
mule deer (15, 16). Some of these ERVs reside in the host genome
as intact proviruses, while others appear to have been generated
through reassortment or recombination among inactivated pro-
viruses (17–19). The hosts have some silencing mechanisms
against these potentially active ERVs; however, failure of their
suppression can cause malignant diseases, such as leukemia or
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lymphoma (18–20) in mice, or can alter phenotypes in domestic
cats (21) or in mice (22) by insertional mutagenesis.
Retroviruses, including ERVs, typically consist of gag, pol, and
env genes with two flanking noncoding long terminal repeats
(LTRs). The LTRs contain a transcriptional start site and various
regulatory cis elements, which act as a promoter and an enhancer
that determine viral transcriptional tropism (23). Hosts often tar-
get the ERV LTRs via epigenetic mechanisms, such as nucleotide
CpG methylation or suppressive histone modification, to silence
the ERVs (24, 25).
ERV in domestic cats (Felis silvestris catus) (26, 27), termed
ERV-DC (28), is one of the youngest feline ERV groups. We pre-
viously identified and molecularly cloned 13 loci of ERV-DC (28).
These ERVs belong to the gammaretrovirus genus, and they ini-
tially invaded the cat genome 2.8 million years ago (28). This
invasion is ongoing, and today, cats generally have 7 to 16 copies
of ERV-DC in their genomes (28). ERV-DCs are classified into
three different genotypes: genotype I (ERV-DC1, -DC2, -DC3,
-DC4, -DC8, -DC14, -DC17, and -DC19), genotype II (ERV-DC7
and -DC16), and genotype III (ERV-DC6, -DC10, and -DC18)
(28). Notably, ERV-DC10 and ERV-DC18 reside in the feline ge-
nome and retain their capacities for infection and replication.
ERV-DC10 and ERV-DC18 are located on chromosome C1q12-
q21 and in the D4q14 region, respectively, and their sequences are
completely identical except for one nucleotide in the U5 primer
binding site (U5-PBS) of tRNAGly. ERV-DC18 is found in only a
certain family of cats, and so this virus seems to have been gener-
ated by reinfection by ERV-DC10 (28). Thus, ERV-DCs are capa-
ble of giving rise to new provirus insertions in vivo. Furthermore,
ERV-DCs can behave as donors and/or acceptors of viral recom-
bination and generate novel exogenous recombinant viruses,
termed feline leukemia virus (FeLV) subgroup D (FeLV-D) (28).
Thus, ERV-DCs can still impact the lives of their hosts through
both their potential replication activity and their contribution to
the emergence of recombinant viruses.
In addition to those described above, the feline genome con-
tain other types of ERV-DCs, ERV-DC7 and ERV-DC16. Both of
these ERVs encode Refrex-1, a restriction factor against ERV-DC
genotype I and FeLV-D, in their truncated env open reading
frames (ORFs) (29). ERV “domestication” is a phenomenon in
which ERVs gain a physiological function, such as placentation or
viral resistance, and eventually evolve into host genes (30, 31).
ERV domestication has occurred through multistep modifica-
tions of the viral genes, including mutations as well as allelic or
nonallelic gene conversions (32, 33). Refrex-1 appears to be a typ-
ical example of ERV domestication, as are Fv1 (34), Fv4 (35),
Rmcf (36), Rmcf2 (37), and endogenous Jaagsiekte sheep retrovi-
rus (enJSRV) (33, 38), which all play a role in viral resistance.
In this study, we identified another replication-competent
ERV, ERV-DC14. ERV-DC14 differs from ERV-DC10 and ERV-
DC18 (ERV-DC10/DC18) in its phylogeny, receptor usage, and,
especially, transcriptional activities. Thus, two distinct subsets of
infectious ERVs reside in the feline genome. Furthermore, to ex-
plore how the host controls these infectious ERVs, we investigated
ERV-DC transcription and its regulatory mechanism. Our results
reveal that these two distinct types of infectious ERVs are con-
trolled by two different mechanisms. These findings demonstrate
the regulatory effects of the interplay between ERVs and hosts.
MATERIALS AND METHODS
Ethics approval. Animal studies were conducted according to guidelines
for the care and use of laboratory animals of the Ministry of Education,
Culture, Sports, Science, and Technology, Japan (73). All experiments
were approved by the Genetic Modification Safety Committee of Yama-
guchi University.
Cells. HepG2 (39), HeLa (40), MCF7 (41), Cos7 (42), HEK293T (43),
AH927 (44), G355 (45, 46), CRFK (47), NIH 3T3 (48), Vero (49), BHK-21
(50), MDTF (51), 104C1 (52), KwDM (28), and MDBK (53) cells were
cultured in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal calf serum. HepG2, HeLa, MCF7, and Cos7 cells were obtained from
the Center for Gene Research, Yamaguchi University. HEK293T, AH927,
G355, CRFK, and NIH 3T3 cells were obtained from Sandra Ruscetti
(National Cancer Institute [NCI]). Vero and BHK-21 cells were obtained
from the Cell Resource Center for Biomedical Research, Institute of De-
velopment, Aging, and Cancer, Tohoku University. MDTF cells were ob-
tained from Yoshinao Kubo (Nagasaki University). 104C1 cells were ob-
tained from the JCRB (Japanese Collection of Research Bioresources) cell
bank. MDBK cells were obtained from Kenji Baba (Yamaguchi Univer-
sity). 293Lac cells (54) were established by transfecting HEK293T cells
with the LacZ-coding retroviral vector pMxs-nLIP (28). The LacZ-coding
retroviral vector is rescued in the presence of a replication-competent
ERV in 293Lac cells. These cells were also maintained in Dulbecco’s mod-
ified Eagle’s medium supplemented with 10% fetal calf serum.
Viruses. ERV-DC10 (28), ERV-DC18 (28), ERV-DC14 (28), and
ERV-DC14TA were prepared by transfecting each plasmid into HEK293T
cells or 293Lac cells by using Lipofectamine 3000 (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions. Culture superna-
tants were collected 3 days after transfection, filtered through 0.45-m-
pore-size filters, and stored as virus stocks at 80°C until use. ERV-
DC14TA, which contains a substitution of T to A at positions 281 and
8598 in the LTRs of ERV-DC14, was constructed by using QuikChange II
site-directed mutagenesis kits (Agilent Technologies, Santa Clara, CA,
USA) according to the manufacturer’s instructions, with the following
complementary primers: DC8-mu6S (5=-CTC CAA GTT GCA TCA GCC
GAG AGA AAC TCC-3=) and its complementary sequence (5=-GGA GTT
TCT CTC GGC TGA TGC AAC TTG GAG-3=).
Infection assay. Target cells were infected with the viral stocks in the
presence of 8 g/ml of Polybrene (Santa Cruz Biotechnology, Inc., Dallas,
TX, USA). Two or three days after infection, the cells were stained with
X-Gal (5-bromo-4-chloro-indolyl--D-galactopyranoside; Wako, Osaka,
Japan), and viral titers were determined as infectious units (IU) per mil-
liliter by counting blue-stained nuclei.
Virus purification. Culture supernatants (5 ml) were collected, fil-
tered through 0.45-m-pore-size filters, and ultracentrifuged for 30 min
at 29,000  g at 4°C in an Optima Max-XP ultracentrifuge (Beckman
Coulter KK, Ariake, Tokyo, Japan). The virions were resuspended in 30
l of phosphate-buffered saline (PBS) and were used for Western blot
analyses.
Immunoblotting. Cells were lysed in buffer (20 mM Tris-HCl [pH
7.5], 150 mM NaCl, 10% glycerol, 1% Triton X-100, 2 mM EDTA, 1 mM
Na3VO4, and 1 g/ml each of aprotinin and leupeptin), followed by in-
cubation on ice for 20 min. Insoluble components were removed by cen-
trifugation at 18,000  g for 20 min at 4°C, and the protein concentrations
of the resulting samples were determined by using a protein assay kit
(Bio-Rad Laboratories, Carlsbad, CA, USA) according to the manufactur-
er’s instructions. Simultaneously, culture supernatants were collected,
and the viruses were purified as described above. Proteins were separated
by electrophoresis on 7.5% or 10-to-20% gradient Tris-glycine minigels
(Oriental Instruments Co., Ltd., Kanagawa, Japan) under reducing con-
ditions (3.5  102 M 2-mercaptoethanol) and then transferred via elec-
trophoresis onto nitrocellulose filters for Western blotting with goat anti-
RD-114 (NCI, Frederick, MD, USA), goat anti-FeLV gp70 (NCI), and
mouse anti-human -actin (Santa Cruz Biotechnology). The blots were
incubated with a horseradish peroxidase (HRP)-conjugated anti-goat IgG
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(Santa Cruz Biotechnology) or an anti-mouse IgG (GE Healthcare Japan,
Tokyo, Japan) secondary antibody, followed by visualization using a 20
LumiGLO instrument (Cell Signaling Technology, Danvers, MA, USA).
Detection of ERV-DCs by reverse transcription-PCR (RT-PCR). Fe-
line tissues were obtained from a specific-pathogen-free (SPF) cat (Kyoto-
SPF1) described in our previous study (29). Peripheral blood samples
were obtained from seven healthy domestic cats. Total RNA was extracted
from cells or tissues with an RNAiso Plus kit (TaKaRa, Kyoto, Japan)
according to the manufacturer’s instructions, and cDNA was synthesized
with a PrimeScript II first-strand cDNA synthesis kit (TaKaRa) according
to the manufacturer’s instructions for inclusion in a treatment with re-
combinant DNase I (TaKaRa). Viral RNA was isolated from cell culture
supernatants by using the QIAamp viral RNA minikit (Qiagen, Tokyo,
Japan) according to the manufacturer’s instructions. PCR was performed
by using a Kod Fx Neo kit (Toyobo Co., Osaka, Japan) with primer set
Fe-13S (5=-CGG TCC AGC TAG CCA TCC CAG TC-3=) and Fe-18R
(5=-ACA GAT CTG CCG CCG GGT TCG TAG TGG CC-3=) for env and
primer set Fe-73S (5=-AAT TTG GAC CTC CGG TTA CCT TG-3=) and
Fe-96R (5=-TTC CTT TCG GGG AAG GAC TA-3=) for pol, and for hu-
man -actin, previously reported primers were used (28).
Qualitative PCR of ERV-DCs was conducted by using the cDNAs de-
scribed above. The expression of ERV-DC was detected via PCR using
primers Fe-184S (5=-CCT AGG RGC TTG GBT CCY AAC ATT TGG
TG-3=) and Fe-168R (5=-GAA GRT AGG GTG GGG GTG TKT TAG TAA
GCT A-3=), which were designed for the end of the 5= LTR and the start of
the 3= LTR, respectively (29). PCR fragments were cloned into a pCR-
Blunt vector (Invitrogen) and then sequenced. ERV-DC genotype-spe-
cific SYBR green-based quantitative PCR was established. cDNA from
feline tissues was amplified with SYBR Premix Ex Taq II (Tli RNase H
Plus; TaKaRa) in a CFX96 Touch real-time PCR detection system (Bio-
Rad Laboratories) by using the following primer pairs: Fe228S (5=-GCT
TGC ACT TCC ACC AGT TG-3=) and Fe205R (5=-ACC TGT TCC TGT
CTT GCG TAG-3=) for ERV-DC genotype I, Fe232S (5=-GCC AGA TAC
AAT CGA ATG AAA GG-3=) and Fe206R (5=-TGC CAA CTG GTT TTG
TTA CTT ATG-3=) for ERV-DC genotype II, and Fe230S (5=-GCC TCC
CTA CCC GAC TTC C-3=) and Fe207R (5=-AGG GGG TTT AGC CGT
TAG G-3=) for ERV-DC genotype III. The gene for feline peptidyl prolyl
isomerase A (PPIA) was used as a reference gene (55).
Transmission electron microscopy (TEM). HEK293T cells trans-
fected with ERV-DC14 or ERV-DC14TA were washed with PBS, fixed
with 2% glutaraldehyde at 4°C for at least 2 h, washed with PBS again, and
postfixed with 2% osmium tetroxide for 1.5 h. Cells were dehydrated
through a graded ethanol series followed by propylene oxide and then
embedded in Epon 812 (TAAB Laboratories Equipment Ltd., Aldermas-
ton, Berks, United Kingdom) for 48 h at 60°C. Ultrathin sections were
stained with uranyl acetate and lead citrate and then examined with an
electron microscope (JEM-1200EX; JEOL, Tokyo, Japan).
Fluorescence in situ hybridization analysis. Feline peripheral blood
mononuclear cell (PBMC) cultures stimulated with 3 g/ml of conca-
navalin A (Sigma-Aldrich, St. Louis, MO, USA) were treated with 25
g/ml E5-bromo-2=-deoxyuridine (Sigma-Aldrich) for 5.5 h, subse-
quently treated with 20 ng/ml of colcemid (Nacalai Tesque, Kyoto, Japan)
for 0.5 h, and then harvested. Replication-banded chromosomes were
obtained by exposure of the chromosome slides to UV light after staining
with Hoechst 33258. pGM14L2 (2.0 kb of ERV-DC14 flanking sequences
amplified by PCR with primers Fe-245S [5=-GAG CCC TGG TGC ACC
AGT AAA GA-3=] and Fe-413R [5=-CCT AGT GCT CAT GGG GAA
AA-3=]) was labeled with digoxigenin-11-dUTP by nick translation for
use as probes. After hybridization, the slides were washed, and the probe
signals were detected with Cy3-labeled antidigoxigenin. Fluorescence in
situ hybridization (FISH) images were captured with the CW4000 FISH
application program (Leica Microsystems, Wetzlar, Germany).
Bisulfite cytosine methylation analysis. Genomic DNAs from feline
blood and virus-infected HEK293T cells were isolated by using a QIAamp
DNA blood minikit (Qiagen) according to the manufacturer’s instruc-
tions. The ERV-DC LTR DNA methylation patterns were investigated by
using a MethylEasy Xceed Rapid DNA bisulfite modification kit (TaKaRa)
according to the manufacturer’s instructions. The 5= LTRs of ERV-DCs
were amplified by using nested PCR with locus-specific or ERV-DC10/
DC18-specific primer pairs (listed in Table 1) in ERV-DC10- or ERV-
DC18-infected HEK293T cells in combination with bisulfite-treated
genomic DNA (listed in Table 2). TaKaRa Taq Hot Start or TaKaRa
EpiTaq HS DNA polymerases were used in these PCR assays according to
the manufacturer’s instructions. The amplicons were cloned into
pGEM-T (Promega), and 12 clones for each sample were used for the
determination of their sequences. The bisulfite data were also analyzed by
using QUMA software (http://quma.cdb.riken.jp/). To make a statistical
judgment on the methylation rate of each CpG position, we used a 90%
confidence interval of the mean methylation rate value for each of the
ERV-DC proviruses. When the methylation rate of a CpG position ex-
ceeded the upper limit of the 90% confidence interval, we considered the
methylation rate of that CpG position to be significantly higher (P 
0.05). The calculation of the confidence interval was performed by using
SAS 9.4 (SAS Institute, Inc., Cary, NC, USA).
Luciferase reporter assay. The reporter plasmids pLTR DC1-Luc,
pLTR DC4-Luc, pLTR DC7-Luc, pLTR DC8-Luc, pLTR DC10-Luc,
pLTR DC14-Luc, pLTR DC16-Luc, pLTR DC17-Luc, and pLTR DC19-
Luc were constructed as described below. The 5= LTR of each ERV-DC
provirus (28, 29) was amplified by using PCR with the specific primers
listed in Table 3. The forward primers bind upstream of the 5= LTR and
contain a KpnI site, and the reverse primer (Fe-157R) binds downstream
of the 5= LTR and has a SacI linker. Each resulting KpnI and SacI fragment
of the LTR was cloned upstream of the luciferase gene in the
pGL4.10[luc2] vector (Promega, Madison, WI, USA).
Chimeric pLTR DC8/DC19-luc was generated by the ligation of the
KpnI and SmaI fragments of pLTR DC8-luc with the SmaI and SacI frag-
ments of pLTR DC19-luc in the pGL4.10[luc2] vector. Chimeric pLTR
DC19/DC8-luc was similarly generated by the ligation of the KpnI and
SmaI fragments of pLTR DC19-luc with the SmaI and SacI fragments of
pLTR DC8-luc in the pGL4.10[luc2] vector.
Reporter plasmids with a point mutation in the LTR, pLTR DC8-mu6,
pLTR DC8-mu7, pLTR DC8-mu8, pLTR DC10-A281T, and pLTR DC19-
A285T, were generated by site-directed mutagenesis using pLTR DC8-
Luc, pLTR DC10-Luc, and pLTR DC19-Luc as the templates along with
the complementary primers listed in Table 3.
Each LTR reporter plasmid (1 g) together with Renilla luciferase-
expressing plasmid phRL-CMV (50 ng) were cotransfected into cells cul-
tured in 12-well plates by using Lipofectamine 2000 (Invitrogen). Lucif-
erase and Renilla luciferase activity levels were measured from the cell
lysates 48 h after transfection by using the Dual Luciferase reporter assay
system (Promega) according to the manufacturer’s instructions. Statisti-
cal analyses of the obtained results were performed by using Student’s t
tests.
In vitro methylation of reporter plasmids. Reporter plasmids (3 g)
were treated with either CpG methyltransferase (M.SssI) or heat-inacti-
vated M.SssI (20 min at 65°C) supplemented with 160 M S-adenosyl-
methionine (SAM) for 4 h at 37°C, and the plasmids were then extracted
with phenol-chloroform, followed by ethanol precipitation. To determine
the methylation levels, the DNAs were treated with the CpG methylation-
sensitive restriction enzyme BstUI, separated by gel electrophoresis, and
then visualized by ethidium bromide staining.
Phylogenetic analysis of ERV-DC LTRs. We constructed a phyloge-
netic tree of the LTRs harbored by ERV-DC proviruses based on the
following sequences: the ERV-DC1 5= LTR (GenBank accession number
AB674439.1), the ERV-DC2 5= LTR (accession number AB674452.1), the
ERV-DC3 5= LTR (accession number AB674440.1), the ERV-DC4 5= LTR
(accession number AB674441.1), the ERV-DC6 3= LTR (accession num-
ber AB674450.1), the ERV-DC7 5= LTR (accession number AB807599.1),
the ERV-DC8 5= LTR (accession number AB674443.1), the ERV-DC10 5=
LTR (accession number AB674444.1), the ERV-DC14 5= LTR (accession
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number AB674445.1), the ERV-DC16 5= LTR (accession number AB807
600.1), the ERV-DC17 5= LTR (accession number AB674446.1), the ERV-
DC18 5= LTR (accession number AB674447.1), and the ERV-DC19 5=
LTR (accession number AB674448.1). Multiple-sequence alignments of
LTRs were generated by using MUSCLE (56). Nucleotide substitution
models based on a Kimura 2-parameter model (57) were selected based on
their Bayesian information criterion scores (58). A phylogenetic tree was
constructed by using the maximum likelihood method, and its robustness
was evaluated by bootstrapping (1,000 times).
We next obtained ERV-DC LTRs from a reference genome of F. catus
(ICGSC Felis_catus 6.2/felcat5) by using the BLAT program implemented
in the UCSC (University of California—Santa Cruz) genome browser
(http://genome.ucsc.edu/), and we conducted phylogenetic analyses with
them. The 5= LTRs of ERV-DC14, -DC7, and -DC10 were used as the
search queries. LTRs containing deletions or missing data were eliminated
from this analysis. Additionally, RD-114 LTRs were also eliminated based
on the 5= portions of their LTR sequences, which have a large insertion/
deletion between ERV-DC and RD-114. In this search, 92 ERV-DC LTRs
were identified, and most of them were solo LTRs. Multiple LTR align-
ments were generated by using MUSCLE (56). Nucleotide substitution
models based on the Kimura 2-parameter model (57) with an inferred
proportion of invariable sites (I 	 0.552039) were selected based on
their Bayesian information criterion scores (58). A phylogenetic tree was
constructed by using the maximum likelihood method, and its robustness
was evaluated by bootstrapping (1,000 times). All programs used in this
study were packaged in MEGA6 (59). The statistical analysis of ERV-DC
invasion of the cat genome was performed by using a chi-squared test.
RESULTS
ERV-DC14 is an infectious virus. We previously identified 13 ERV-
DCs in domestic cats. Of these proviruses, ERV-DC10 and ERV-
DC18 have now been established as replication-competent viruses
(28), but although ERV-DC14 also has intact open reading
frames, our previous work did not include an in-depth study of
the viral infectivity of this provirus. Therefore, we began this study
by determining whether or not ERV-DC14 is replication compe-
tent and infectious.
We initially established indicator cells, termed 293Lac cells
(54), by stably transfecting a LacZ-expressing retroviral vector,
pMxs-nlLacZ, into HEK293T cells to monitor viral infection and
replication. The supernatant from 293Lac cells transfected with a
full-length ERV-DC14 plasmid was filtered and then used to treat
fresh HEK293T cells for 2 days, after which LacZ staining was
performed. As shown in Fig. 1A, treatment with the supernatant
TABLE 1 PCR primers used for analysis of ERV-DC LTR DNA methylation patternsa
5= LTR of ERV-DC Forward primer Forward primer sequence (5=–3=) Reverse primer Reverse primer sequence (5=–3=)
ERV-DC1 Fe-155S GTTAGGGAGAGGGTTTTATTGTTT Fe-144R ACAAAAATCTATCTTCAATCAATCC
Fe-156S GGTTTTTGGAAATATGTTTTTAAA Fe-145R CAAAACATAAAACACAATACCTATATACAA
ERV-DC3 Fe-157S TTTTAGAAATTAAAAAGAAGGTAGGAGAGT Fe-146R ACCTCAAAATTCACAATTCAAAAAC
Fe-158S TGAGTATGTTTAATGTAATTTTTTAAATT Fe-147R CTTCAACACTCCTACTAAAATAACC
ERV-DC4 Fe-159S GTTAATTTATTTTGGGTGTAGTGAT Fe-144R
Fe-160S TGTGTATTTAGTAGTGGGTTTTTTAG Fe-148R AAAATTCACAATTCAAAAACAAAAC
ERV-DC7 Fe-161S AGTAAATGGGTATTGAGTTGGGTAAT Fe-149R TATACAAACAAAAATACAAAAATCC
Fe-162S TTAAGAAAGAATTTATTGAGAATATAA Fe-150R AATACAAAAACAAAACACAATACCT
ERV-DC8 Fe-163S TTTTTAGGGTAATATTGGAGTTTAA Fe-144R
Fe-164S TGGATAATAAATTTAGGATGTTAGAATTAT Fe-151R CAATTCAAAAACAAAACATAAAACAC
ERV-DC10 Fe-150S TTTTAGTGGGGATTTTGTAAATTGGT Fe-143R AACATAAAACACAATACCTATATACAAACA
Fe-154S TTTTGGTAGTTTTATAAGAGAAAAGAGAGA Fe-142R TCTATCCTCCTTCAACACTCCTACTAAAAT
ERV-DC14 Fe-165S TTTAGATTTGTAGTTAAGGGATTGTG Fe-147R
Fe-166S GTAGATTTGTTATTAAATTGGTTTTTAGG Fe-152R ATAACAAAAAAAACCTACCTTC
ERV-DC16 Fe-225S AGAAATGGTTAAGGAAAGTTTTAGGTT Fe-147R
Fe-226S AGGTTTAAATTTGAAAGATTTTTGTTTAGT Fe-149R
ERV-DC17 Fe-167S ATATAGTTTGGGGGATGAGATTATTTATTA Fe-153R AAATTCTCCTACCTTCCCTCTCTT
Fe-168S TTAAGAGTTTTAAAATTTGTTTTTG Fe-144R
ERV-DC18 Fe-152S TAAGGAGAGTTTGAATAAGGTTAAGGTTG Fe-142R
Fe-153S GAGTAGTGGGAGGTGTTTGGTTT Fe-143R
ERV-DC19 Fe-169S TAGTGGGATTTTTAAATGTAATGTT Fe-169R CAAAAACACAAAAATCTATCTTCAATC
Fe-170S GTTGATTAGAAGTTTGGTGGGTT Fe-151R




a The 5= LTRs of ERV-DCs were amplified by nested PCR using locus-specific or ERV-DC10/DC18-specific primer pairs.
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from ERV-DC14-transfected cells produced a LacZ titer of 103
IU/ml. Treatment with the supernatant from ERV-DC10-trans-
fected cells produced a much higher viral titer (2  104 IU/ml)
than did treatment with the supernatant from ERV-DC14-trans-
fected cells. As expected, HEK293T cells treated with the superna-
tant from mock-transfected cells were not LacZ positive (Fig. 1A).
Western blot analyses showed that viral proteins correspond-
ing to Gag and Env were detected with 73S-045 (anti-Gag/Pol)
and 81S-210 (anti-Env) antisera, respectively, in the cell lysates
(Fig. 1B) and in the supernatants (Fig. 1C) from cells transfected
with ERV-DC14 or ERV-DC10. Furthermore, when the superna-
tants from HEK293T cells that had been transfected with ERV-
DC14 or ERV-DC10 were used to treat uninfected HEK293T cells
for 2 days, ERV-DC14 and -DC10 viral mRNA and virions were
detected by RT-PCR with ERV-DC-specific env primers in the
cells themselves (Fig. 1D) as well as in the supernatants of the cells
(Fig. 1E). These results demonstrate that ERV-DC14 is a replica-
tion-competent virus and is capable of being transmitted among
cells. The levels of viral transcription, production, replication, and
transmission of ERV-DC14 were all lower than those of ERV-
DC10.
To define the ERV-DC14 locus, we conducted fluorescence in
situ hybridization (FISH) analysis using the 2.0-kb ERV-DC14
flanking sequences that had been amplified by PCR as a FISH
probe. ERV-DC14 was mapped to feline chromosome C1q32 (Fig.
2). These results indicate that ERV-DC14 and -DC10 (located on
chromosome C1q12-21) (28) are located on the same chromo-
some but are completely distinct from each other.
Expression of ERV-DCs in feline tissues. Although we have
previously shown that Refrex-1, which is encoded by both the
ERV-DC7 and ERV-DC16 loci, is expressed in domestic cats (29),
it remained unclear whether or not the other ERV-DCs were also
expressed in feline tissues. Therefore, we attempted to determine
the overall expression of ERV-DCs in an SPF cat. cDNA was ob-
TABLE 2 Information on the 5= LTRs of ERV-DC and DNA samples used for analysis of ERV-DC LTR DNA methylation patternsa
ERV-DC Length of 5= LTR (bp) No. of CpGs Cat or cell line Genotype Viral source
ERV-DC1 550 22 ON-C /, GI
ERV-DC3 550 22 ON-C /, GI
ERV-DC4 550 22 GF33 /, GI
ERV-DC7 545 25 GF33 /, GII
ERV-DC8 550 21 GF33 /, GI









293T/AH927 cells Infection AH927
293T/GF33 cells Infection GF33
293T/HK25 cells Infection HK25
293T/NS14 cells Infection NS14
293T/TK14 cells Infection TK14
293T/YG22 cells Infection YG22
ERV-DC14 551 21 SO38 /, GI
ERV-DC16 575 26 GF33 /, GII
ERV-DC17 551 21 ON-C /, GI
ERV-DC18 551 26 ON-C /, GIII
ON-H /, GIII
ON-T /, GIII
293T/ON-C cells Infection ON-C
293T/ON-H cells Infection ON-H
293T/ON-T cells Infection ON-T
ERV-DC19 555 20 IS10 /, GI
a DNA samples from cats or from feline AH927 cells were used in this study. The length of the 5= LTR, number of CpG sites, and genotype of the ERV-DCs are shown. In the
genotype column, / indicates heterozygous, / indicates homozygous, and infection indicates that the corresponding viruses from cats can replicate in HEK293T cells.
HEK293T cells infected with ERV-DC10 or ERV-DC18 were described in a previous study (28). GI, genotype I; GII, genotype II; GIII, genotype III.
Transcriptional Regulation of Infectious Feline ERVs
October 2016 Volume 90 Number 20 jvi.asm.org 9033Journal of Virology
tained from the tissues of an SPF cat, and ERV-DC transcripts
were amplified by using RT-PCR with the ERV-DC-specific prim-
ers Fe-184S and Fe-168R, which correspond to the 5= and 3= LTRs,
respectively, and these amplicons were then cloned and se-
quenced. Sequence analysis indicated that the 2.5-kb fragments
were env subgenomic RNA. Several different transcripts of env
genes were detected from feline tissues, and they were genotyped
by constructing a phylogenetic tree (Fig. 3A). A schematic of Env
encoded in these transcripts is shown in Fig. 3B. All three ERV
genotypes (genotypes I, II, and III) were expressed in feline tissues
(Fig. 3C). Three of the env genes (env a, env b, and env e) encode
full-length Env, while two of them (env c and env d) encode trun-
cated Env proteins corresponding to Refrex-1, which is derived
from the ERV-DC7 and ERV-DC16 env genes (29). The env a and
env b sequences are highly similar to the env sequences for ERV-
DC8 and -DC14, respectively, both of which are classified as ge-
notype I ERV-DCs. The env e sequence is highly similar to that
of the ERV-DC10 (a genotype III ERV-DC) env gene. The env
genes differ by 0 to 3 bp in comparison with the reference
sequences. Notably, the SPF cat used in this study did not have
ERV-DC19.
Next, we performed quantitative RT-PCR (qRT-PCR) assays
with primer pairs that are specific for ERV-DCs belonging to ge-
notype I, II, or III. The total gene expression level of each ERV-DC
genotype was adjusted based on the PPIA expression level (Fig.
3C). The expression level of ERV-DC genotype II, which includes
Refrex-1, was high in PBMCs, and this genotype was broadly ex-
pressed in most tissues (Fig. 3C). In contrast, ERV-DC in geno-
types I and III showed limited expression in all of the tested feline
tissues (Fig. 3C). These results show that the expression levels of
ERV-DCs differ among their genotypes and loci, indicating that
their promoter activities also vary. Notably, the expression level of
TABLE 3 PCR primers used in the construction of the reporter plasmidsa
Reporter plasmid Primer Sequence (5=–3=)
pLTR DC1-Luc Fe-174S AAAGGTACCAAACATGGCAGCATTTGTGG
Fe-157R TTTGAGCTCACCGACGGGGCCGGGGTTCTC
pLTR DC4-Luc Fe-175S AAAGGTACCCAATTTACCTTGGGTGCAGTGA
Fe-157R
pLTR DC7-Luc Fe-199S AAAGGTACCTGCAATTTGGGAGACACAGACT
Fe-157R
pLTR DC8-Luc Fe-176S AAAGGTACCGCCTTCACACTGGGAGAGATTT
Fe-157R
pLTR DC10-Luc Fe-190S AAAGGTACCATCCTGTGAGTTGGTGAGAGACC
Fe-157R
pLTR DC14-Luc Fe-178S AAAGGTACCTGCAGTTAAGGGACTGTGGACT
Fe-157R
pLTR DC16-Luc Fe-223S AAAGGTACCGCCACGGTCATGAAAATAAAAA
Fe-157R
pLTR DC17-Luc Fe-179S AAAGGTACCCAGCTTGGGGGATGAGATTATT
Fe-157R
pLTR DC19-Luc Fe-180S AAAGGTACCGAAACCTCCCACAAAAGTCCAC
Fe-157R
pLTR DC8-mu6 DC8-mu6S CTCCAAGTTGCATCAGCCGAGAGAAACTCC
DC8-mu6R GGAGTTTCTCTCGGCTGATGCAACTTGGAG
pLTR DC8-mu7 DC8-mu7S CTCTCTGCCGAAGTCGGAGTGCCGTGTGGT
DC8-mu7R ACCACACGGCACTCCGACTTCGGCAGAGAG
pLTR DC8-mu8 DC8-mu8S CGTGTGGTTCTTTGCACCAACTCTCATTCCATAG
DC8-mu8R CTATGGAATGAGAGTTGGTGCAAAGAACCACACG
pLTR DC10A281T DC10-mu1S GGCTCCAAGTTGCATCTGCCAAAAGAAACTTCA
DC10-mu1R TGAAGTTTCTTTTGGCAGATGCAACTTGGAGCC
pLTR DC19A285T DC19-mu1S CTCCAAGTTGCATCTGCCGAGAGAAACTCC
DC19-mu1R GGAGTTTCTCTCGGCAGATGCAACTTGGAG
a Plasmids pLTR DC1-Luc, pLTR DC4-Luc, pLTR DC7-Luc, pLTR DC8-Luc, pLTR DC10-Luc, pLTR DC14-Luc, pLTR DC16-Luc, pLTR DC17-Luc, and pLTR DC19-Luc were
constructed by PCR amplification with specific primer pairs. Reporter plasmids pLTR DC8-mu6, pLTR DC8-mu7, pLTR DC8-mu8, pLTR DC10-A281T, and pLTR DC19-A285T
containing a point mutation in the LTR were generated by site-directed mutagenesis using complementary primers.
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genotype III was very low, even though this group contains ERV-
DC10, which can replicate in cultured cells at high levels.
Additionally, we examined ERV-DC expression levels in PBMCs
from seven healthy domestic cats. We observed the same trends in
these cells that we saw in feline tissues: the expression level of
genotype II is high, whereas that of genotype III is low (Fig. 3C and
D). Although ERV-DC insertional polymorphism exists in do-
mestic cats, a preference for promoter activity may affect gene
expression in feline tissues. In summary, ERV-DCs are expressed
in normal tissues, and most ERV-DC transcripts belong to geno-
type II.
CpG methylation status of the ERV-DC LTRs. The ERV-DC
expression levels in feline tissues differed among the three geno-
types. High expression levels were observed for genotype II ERV-
DC, which includes the Refrex-1-coding loci ERV-DC7 and ERV-
DC16, whereas low expression levels were observed for genotype
III ERV-DCs, despite the inclusion of a highly replication-compe-
tent provirus, ERV-DC10/DC18, in this group. These findings
indicate that the transcriptional regulation of viral genes or ge-
nomes differs among ERV-DC loci. Therefore, we next investi-
gated how ERV-DC expressions are regulated.
We first examined the methylation status of CpG nucleotides
in the 5= LTR of each ERV-DC provirus, which functions as the
viral promoter and enhancer. For the analysis of CpG methyl-
ation, we used the sodium bisulfite sequencing technique and an-
alyzed the genomic DNA from the blood of eight different cats as
well as from one feline fibroblast cell line, AH927. We selected
blood samples for use in this experiment because, compared to
their expression levels in other tissue types, all three ERV-DC
types are relatively well expressed in blood cells (Fig. 3C). The
samples, 5=-LTR lengths, numbers of CpG sites within the 5= LTR,
and basic information for each of the ERV-DC loci are summa-
rized in Table 2.
As shown in Fig. 4 and 5, the ERV-DC10 5= LTR in feline
genomic DNA from the tested samples was densely methylated.
The methylation status was not dependent on whether the ERV-
DC10 locus was a heterozygote or a homozygote. The ERV-DC18
FIG 1 Assessment of the replication competence of ERV-DC14. (A) 293Lac cells were transfected with plasmids containing ERV-DC10 or ERV-DC14 or were
mock transfected, and the supernatants were then collected and used to infect HEK293T cells. Cells were fixed at 48 h postinfection and visualized by X-Gal
staining (top). The viral titers are expressed as infectious units (IU) per milliliter (bottom) with standard deviations. nd, not detected. (B) Western blot analysis,
using an anti-RD-114 (an anti-Gag/Pol) antibody (Ab), of cell lysates from HEK293T cells at 48 h posttransfection that had been transfected with plasmids
containing ERV-DC10 or ERV-DC14 or that had been mock transfected. The membranes from the original Western blot assay were stripped and reanalyzed by
using an anti--actin antibody. Arrows indicate ERV-DC-specific bands. (C) Western blot analysis of purified virions using anti-Env antibody. Virions were
purified at 48 h posttransfection from the culture supernatants of HEK293T cells that had been transfected with plasmids containing ERV-DC10 or ERV-DC14
or that had been mock transfected. The asterisk indicates a nonspecific band. (D) Detection of ERV-DC env mRNA in HEK293T cells 48 h after infection with
ERV-DC10, ERV-DC14, or mock virus by RT-PCR. (E) Detection of viral RNA in the supernatant of HEK293T cells 48 h after infection with ERV-DC10,
ERV-DC14, or mock virus by RT-PCR. DNA was visualized with ethidium bromide staining, and cDNA was synthesized with () or without () reverse
transcriptase (RT).
FIG 2 FISH analysis of ERV-DC14. (Left and middle) Cytogenetic map (left)
and G banding (middle) of feline chromosome C1. (Right) Results of FISH
performed by using 2.0-kb ERV-DC14 flanking sequences as a probe.
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5= LTR also exhibited strong methylation in all three ERV-DC18-
positive samples. The ERV-DC10 and ERV-DC18 LTR sequences
are identical, and they each contain 26 positions of CpG dinucle-
otides in their 5= LTRs. The methylation rates of ERV-DC10 and
ERV-DC18 ranged from 84.3 to 96.2% in nine samples (data for
three samples are not shown) and from 91.7 to 97.8% in three
samples, respectively. Thus, the ERV-DC10 and -DC18 promoters
are strongly methylated in the feline genome. These highly meth-
ylated states were not observed in replicating ERV-DC10 and
ERV-DC18 in HEK293T cells (Fig. 5). In contrast to ERV-DC10/
DC18, the methylation levels of ERV-DC7 and -DC16, both of
which are the loci encoding Refrex-1, were extremely low; the
FIG 3 Expression of ERV-DCs in feline tissues. (A) A phylogenetic tree of the env gene nucleotide sequences was constructed by using the maximum likelihood
method, and its robustness was evaluated by bootstrapping (1,000 times) as previously described (29). ERV-DC env genes, env a to e, were detected in feline
tissues. (B) Schematic of the structure of Env encoded in the identified transcripts of ERV-DCs. sp, signal peptide; SU, surface unit; N-term, N-terminal region
of the surface unit; PRR, proline-rich region; C-term, C-terminal region of the surface unit; TM, transmembrane. (C) Quantifications of ERV-DC transcript
levels determined by qRT-PCR with primer pairs that were specific for ERV-DCs belonging to genotype I, genotype II, or genotype III. The total gene expression
level of each ERV-DC genotype was adjusted according to the expression level of PPIA (55). (D) Expression of ERV-DC genotype I, genotype II, or genotype III
in blood samples from seven healthy domestic cats. The total gene expression level of each ERV-DC genotype was adjusted according to the expression level of
PPIA.
FIG 4 CpG methylation statuses of the ERV-DC provirus 5= LTRs from blood samples. The CpG sites in the 5= LTRs of ERV-DCs were aligned. The CpG
methylation of each of the 5= LTRs from the 11 ERV-DC loci in feline blood genomic DNA was analyzed by using the sodium bisulfite sequencing technique. One
representative result from ERV-DC10 (GF33) and ERV-DC18 (ON-C) is shown. Orange indicates the unmethylated frequency, and royal blue indicates the
methylated frequency. The arrow indicates the position of the TATA box.
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methylation rates of CpG nucleotides in the 5= LTRs of ERV-DC7
and -DC16 were 16.7% and 0%, respectively (Fig. 4).
In PBMCs, the CpG nucleotides in the 5= LTRs of ERV-DC14,
a member of genotype I, were partially methylated (37.7%) (Fig.
4). The CpG nucleotide methylation rate in genotype I ERV-DCs
ranged between 23.1 and 47.6%. Interestingly, this group exhib-
ited lower levels of CpG methylation in the U3 regions but exhib-
ited higher levels of CpG methylation in the R and U5 regions (Fig.
4); in other words, the region downstream of TATA was signifi-
cantly more methylated (P  0.05) than the region upstream of
TATA. Overall, our results show that the methylation status of 5=
LTRs corresponds to the expression levels of ERV-DCs in the
blood (Fig. 3C and D). Moreover, our data show that methylation
in the ERV-DC 5= LTRs can be separated into three levels: high,
medium, and low. Additionally, these methylation levels correlate
with their genotypes: genotypes I, II, and III exhibit medium, low,
and high methylation levels, respectively.
Basal promoter activity of ERV-DC LTRs. Next, we exam-
ined the intrinsic promoter activity of the ERV-DC 5= LTRs by
using luciferase reporter assays. We constructed nine LTR-Luc
reporter plasmids by inserting a 5= LTR from each provirus into
a separate promoterless firefly luciferase reporter plasmid: pLTR
DC1(DC3)-Luc, pLTR DC4-Luc, pLTR DC7-Luc, pLTR DC8-
Luc, pLTR DC10(DC18)-Luc, pLTR DC14-Luc, pLTR DC16-
Luc, pLTR DC17-Luc, and pLTR DC19-Luc. The LTR sequences
for ERV-DC3 and -DC18 were the same as those for ERV-DC1
and -DC10, respectively, and thus, to avoid redundancy, we
made only one reporter plasmid for each of these identical
pairs. Each of the LTR-Luc plasmids were transfected into
AH927 and HEK293T cells, and the luciferase activities were mea-
sured and adjusted according to the Renilla luciferase activity. As
shown in Fig. 6A, the LTRs from ERV-DC7, -DC10, -DC19, and
-DC16 exhibited promoter activity in HEK293T cells (P  0.05).
Similar results were obtained with AH927 cells (data not shown).
ERV-DC7 and -DC16 LTRs had the highest promoter activities
(Fig. 6A). The promoter activities of ERV-DC7, ERV-DC16, and
ERV-DC19 were 1.9-fold (5.1-fold in AH927 cells), 1.5-fold
(4.6-fold in AH927 cells), and 0.3-fold (0.7-fold in AH927 cells)
higher than that of ERV-DC10. No promoter activity was detected
in HEK293T cells (Fig. 6A) transfected with ERV-DC1(DC3),
-DC4, -DC8, -DC14, or -DC17 in comparison with those in cells
transfected with an empty vector. The promoter activity of ERV-
DC14 was detected at very low levels in HepG2 cells (data not
shown). Among genotype I ERV-DCs, only the ERV-DC19 LTR
exhibited detectable promoter activity (Fig. 6A).
Identification of a cis element in ERV-DC LTRs. Of the geno-
type I ERV-DCs, only ERV-DC19 showed any obvious promoter
activity in HEK293T cells; the others did not exhibit detectable
promoter activity in the tested cells. To investigate the reason for
this difference, two chimeric LTRs (the DC8/19 LTR and the
DC19/8 LTR) were initially constructed by using the SmaI restric-
tion enzyme site located in the LTRs of ERV-DC8 and -DC19 at
positions 263 and 267, respectively, (Fig. 6B), and the promoter
activity of these chimeras was assessed by using luciferase reporter
assays. As shown in Fig. 6C, the DC8/19 LTR exhibited promoter
activity, while the DC19/8 LTR did not. This indicates that the
region downstream of the SmaI site is responsible for the differ-
ence in promoter activity between ERV-DC8 and ERV-DC19. A
sequence comparison of this region between ERV-DC8 and ERV-
DC19 revealed the presence of three nucleotide differences: thy-
mine (T) at nucleotide position 280, adenine (A) at position 483,
and guanine (G) at position 508 in the ERV-DC8 5= LTR all differ
from the nucleotides at these positions in the ERV-DC19 5= LTR.
Next, we constructed three ERV-DC8 5=-LTR mutants: the DC8-
mu6 LTR (T-to-A replacement at position 280 in the ERV-DC8 5=
LTR), the DC8-mu7 LTR (A-to-G replacement at position 483 in
the ERV-DC8 5= LTR), and DC8-mu8 LTR (G-to-A replacement
at position 508 in the ERV-DC8 5= LTR) (Fig. 6B). When these
LTR plasmids were transfected into HEK293T cells, only the DC8-
mu6 LTR significantly exhibited any promoter activity (P  0.05).
No promoter activity was observed in HEK293T cells transfected
with DC8-mu7 or DC8-mu8 LTRs (Fig. 6D). These results indi-
cate that the thymine at nucleotide position 280 of the ERV-DC8
5= LTR is responsible for the reduced or absent promoter activity.
Furthermore, we investigated whether or not the promoter activ-
ities of the 5=LTRs from ERV-DC10 and ERV-DC19 were reduced
by the converse mutations at nucleotides 281 and 285, respec-
tively, both of which correspond to nucleotide position 280 in the
FIG 5 CpG methylation statuses of ERV-DC10 and ERV-DC18 5= LTRs. The CpG methylation statuses of the ERV-DC10 or ERV-DC18 5= LTRs in cat blood
or in HEK293T cells that were persistently infected with ERV-DC10 or ERV-DC18 from either feline AH927 cells or blood from healthy cats (28) were analyzed
by using the sodium bisulfite sequencing technique. Each result was derived from 12 sequences produced by sodium bisulfite sequencing. Orange indicates the
unmethylated frequency, and royal blue indicates the methylated frequency. The arrow indicates the position of the TATA box.
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ERV-DC8 5= LTR. We constructed two mutants, the DC10 A281T
LTR (A-to-T substitution at nucleotide position 281 of the DC10
5= LTR) and the DC19 A285T LTR (A-to-T substitution at nucle-
otide position 285 of the DC19 5= LTR). These two mutants ex-
hibited significantly reduced promoter activity levels (P  0.05) in
HEK293T cells (Fig. 6E). Thus, we determined that the nucleotide
substitution responsible for the difference in promoter activities
among the 5= LTRs of ERV-DCs is an A-to-T substitution corre-
sponding to nucleotide 280 in the ERV-DC8 5= LTR. This A-to-T
substitution may disrupt an important cis element at this region
that influences the magnitude of the ERV-DC basal promoter ac-
tivity.
ERV-DC LTR-driven transcription is suppressed by CpG
methylation. Generally, LTR promoter activity is reduced by a
suppressive epigenetic status, such as CpG methylation, so we
tested whether or not the promoter activities of ERV-DC 5= LTRs
were affected by their methylation states in vitro. We induced CpG
methylations of the LTR reporter plasmids of ERV-DC7, -DC10,
-DC16, and -DC19 with either M.SssI or heat-inactivated M.SssI
and confirmed their methylation levels by digesting them with
BstUI, which is a CpG methylation-sensitive restriction enzyme.
As shown in Fig. 7A, all of the plasmid DNA was successfully
methylated.
Next, the methylated or unmethylated LTR plasmids were
transfected into HEK293T cells, and their promoter activities were
assessed. As shown in Fig. 7B, the promoter activity levels of the
methylated plasmids were significantly lower than those of con-
trols in all tested LTRs (P  0.05) (Fig. 7B). Thus, the high meth-
ylation status of CpG nucleotides in the ERV-DC LTRs results in a
reduction of promoter activity in vitro.
Viral properties of ERV-DC14 and the ERV-DC14TA mu-
tant. As shown in Fig. 1, the levels of viral transcription, produc-
tion, replication, and transmission of ERV-DC14 are lower than
those of ERV-DC10. Notably, although ERV-DC14 can replicate
in HEK293T cells, it cannot establish a persistent infection in these
cells. We speculated that the low replication level of ERV-DC14 is
a result of its low promoter activity level, so we constructed a
mutant of ERV-DC14, termed ERV-DC14TA, that has point mu-
tations of T to A at nucleotide 281 in its 5= LTR and at nucleotide
8598 in its 3= LTR (Fig. 8A). This plasmid was transfected into
293Lac cells or HEK293T cells. The viral titer in the supernatant or
virus-infected cells was then tested by LacZ staining, and the ex-
FIG 6 Luciferase reporter assay for basal promoter activity of ERV-DC LTRs and identification of LTR cis elements. (A) The basal promoter activity levels of
wild-type LTRs were measured by using a luciferase reporter assay. Genotype I (GI) includes DC1 (DC3), DC4, DC8, DC14, DC17, and DC19; genotype II (GII)
includes DC7 and DC16; and genotype III (GIII) includes DC10 (DC18). (B) Schematic of chimeric and mutant ERV-DC LTRs that were used to investigate the
presence of a cis element in ERV-DC LTRs. The name of each construct is indicated on the left, and the wild-type status or the chimeric or point mutation of the
LTRs is indicated on the right. Asterisks indicate a point mutation of the nucleotide. The SmaI restriction enzyme site is located in the LTRs of ERV-DC8 and
ERV-DC19 at positions 263 and 267, respectively. (C) The promoter activity levels of chimeric LTRs between the DC19 LTR and DC8 LTR (DC8/19 and DC19/8
LTRs) were measured by a luciferase reporter assay. (D) The promoter activity levels of DC8-mu6 (T280A substitution), DC8-mu7 (A483G substitution), and
DC8-mu8 (G508A substitution), which are all DC8 LTRs containing a point mutation, were measured by a luciferase reporter assay. (E) The promoter activity
levels of DC10 A281T (A281T substitution) and DC19 A285T (A285T substitution), which are the DC10 and DC19 LTRs with a point mutation, respectively,
were measured by a luciferase reporter assay. LTR-Luc reporter plasmids were cotransfected with Renilla luciferase-expressing phRL-CMV into HEK293T cells.
The cells were harvested at 48 h posttransfection, and luciferase activity was measured. The control (Cont) was a pGL4.10[luc2] empty vector. The luciferase
activity of each LTR was adjusted according to the Renilla luciferase activity. The results from three replicates were collected and statistically analyzed by Student’s
t test and one-way analysis of variance (*, P  0.05).
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pression of viral mRNA was assessed by RT-PCR. As shown in Fig.
8B, ERV-DC14TA induced more LacZ staining foci than did ERV-
DC14, and the infection titer of ERV-DC14TA was 10-fold
higher than that of ERV-DC14 at 2 days postinfection. Addition-
ally, when HEK293T cells were infected with ERV-DC14 or ERV-
DC14TA for 2 days, we were able to detect their pol and env genes
by RT-PCR (Fig. 8C). Thus, ERV-DC14TA, like ERV-DC14, is
replication competent, and it can produce more infectious virions
than ERV-DC14.
Next, we monitored viral infections of ERV-DC14, -DC14TA,
and -DC10 in HEK293T cells over the course of several days.
293Lac cells were transfected with each plasmid, and the resulting
supernatants were used to infect HEK293T cells. As shown in Fig.
8C, the viral titers of ERV-DC14TA and ERV-DC10 were 10-
fold higher than that of ERV-DC14 at 2 days postinfection. Sub-
sequently, the ERV-DC14TA and ERV-DC10 infections became
persistent, with viral titers of 104 IU/ml, whereas ERV-DC14
gradually disappeared from 293Lac cells after 10 days and was
unable to maintain viral replication in HEK293T cells. Addition-
ally, we detected infectious ERV-DC14TA in the supernatants
from persistently infected cells by measuring viral infectivity (data
not shown), indicating that, similarly to ERV-DC10, ERV-
DC14TA was persistently produced in HEK293T cells. Thus, al-
though ERV-DC14 cannot establish a persistent infection in
HEK293T cells, this defect can be recovered by T-to-A substitu-
tions at positions 281 and 8598 in the 5= and 3= LTRs, respectively.
We examined ERV-DC14 and ERV-DC14TA by transmission
electron microscopy (TEM) in HEK293T cells. Both ERV-DC14
(Fig. 9A and B) and ERV-DC14TA (Fig. 9C to E) particles were
detected by TEM and morphologically were retrovirus type C.
Figure 9E shows a late stage of budding. Overall, we confirmed
that ERV-DC14 is a replication-competent virus and found that
the ancestral mutation (thymine) of the ERV-DC14 LTR cis ele-
ment reduced its viral replication. Furthermore, these results sug-
gest that this ancestral mutation in the LTR affects the interplay
between the host and the viruses.
ERV-DC14 and ERV-DC10 tropism. Our previous study
demonstrated that ERV-DC14 did not interfere with ERV-DC10,
indicating that these viruses use different viral receptors (29, 32).
In this study, we compared the host ranges of ERV-DC14 and
ERV-DC10 in detail by using the ERV-DC14TA mutant so that it
would be easier to monitor viral infection. As shown in Table 4,
ERV-DC14TA broadly infected all of the tested cell lines, except
for the mouse and hamster cell lines, while ERV-DC10 infected
only a limited subset of the tested cell lines. In these experiments,
we washed Refrex-1 out of the feline cell cultures because ERV-
DC14 infection is affected by the presence of Refrex-1 (29). Most
of the tested human cell lines were similar to one another in their
sensitivities to ERV-DC14TA and ERV-DC10, but MCF7 cells had
a somewhat lower viral titer, suggesting that they are less sensitive
to these viruses and may contain viral resistance factors. These
results indicate that the receptor usages of ERV-DC14 and ERV-
DC10 are different from one another. Moreover, ERV-DC14
broadly infects many species, while ERV-DC10 induced only a
limited infection in the tested cells.
ERV-DC invasion in the cat genome. As described above, we
identified an A-to-T substitution in the LTR, which is commonly
observed in a certain clade of ERV-DC genotype I, and this sub-
stitution is responsible for inducing reductions in viral promoter
activities and for the low replication levels of ERV-DC14. There-
fore, ERV-DC LTRs can be divided into two groups, A-type LTRs
and T-type LTRs (Fig. 10A). A-type LTRs (ERV-DC10/DC18,
-DC7, -DC16, and -DC19) have strong or ubiquitous promoter
activities, whereas T-type LTRs (ERV-DC1, -DC4, -DC8, -DC14,
and -DC17) have weak or attenuated promoter activities (Fig. 6A).
To gain insight into which LTR type is more adaptive to sur-
viving within the host genome, we investigated which LTR type is
more dominant in the ERV-DC population using an in silico anal-
ysis. First, ERV-DC LTRs were extracted from the feline reference
genome (ICGSC Felis_catus 6.2/felcat5) by using the BLAT pro-
gram implemented in the UCSC genome browser. Second, the
LTR type (A or T type) of each locus was checked in a multiple-
FIG 7 ERV-DC LTR-driven transcription in the presence of CpG methylation. (A) The LTR reporter plasmids (DC7, DC10, DC16, DC19, and empty vector)
were methylated in vitro by either M.SssI (Me) or heat-inactivated M.SssI (HI). The DNA was treated with BstUI, separated by gel electrophoresis, and visualized
by ethidium bromide staining. M indicates the DNA marker, and Cont indicates the control pGL4.10[luc2] empty vector. (B) The promoter activity levels of
methylated or unmethylated (treated with heat-inactivated M.SssI) ERV-DC LTRs were measured by a luciferase reporter assay. The LTR-Luc reporter plasmids
were cotransfected with Renilla luciferase-expressing phRL-CMV into HEK293T cells, the cells were harvested at 48 h posttransfection, and luciferase activity was
measured. The control was the pGL4.10[luc2] empty vector. The luciferase activity of each LTR was adjusted according to the Renilla luciferase activity level.
These results include data from three independent replicates and were statistically analyzed by Student’s t test (*, P  0.05).
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sequence alignment. Third, a phylogenetic tree of the identified
LTRs was constructed by using the maximum likelihood method
with bootstrapping (1,000 times). As a result, we identified a total
of 92 ERV-DC LTR loci: 54 of genotype I/type T, 14 of genotype
I/type A, 6 of genotype II, and 18 of genotype III (Fig. 10B and C).
All of the genotype II and III ERV-DCs had A-type LTRs (Fig.
10B). Finally, we compared the copy numbers of LTRs among
groups. This comparison revealed that the proportion of T-type
LTRs is significantly higher than those of the others, both within
the genotype I population (54/68; P  0.001) and within the total
ERV-DC population (54/92; P 	 0.027) (Fig. 10C). These results
indicate that genotype I ERV-DCs bearing an A-to-T substitution
(T-type LTRs) have invaded the feline genome significantly more
than other types have, and they support the idea that ERV-DCs
with a substitution that causes promoter attenuation are more
adaptive to surviving within host genomes.
DISCUSSION
ERV-DC10 and ERV-DC18 are the first feline ERVs that were
identified as replication-competent proviruses residing within the
host genome (32, 60, 61). In this study, we newly identified ERV-
DC14 as another replication-competent ERV and characterized
this virus in detail. Although ERV-DC14 is replication competent,
its level of replication is very low, so this virus does not establish
persist infection in cultured cells. This low level of ERV-DC14
replication results from its low promoter activity level, which is
caused by one A-to-T substitution in each of its LTRs. The lack of
persistent ERV-DC14 infection is the reason why we did not de-
tect the replication-competent ability of ERV-DC14 in our previ-
ous study (28). In this study, we used a previously reported strat-
egy to identify ERVs (62, 63), establishing 293Lac indicator cells,
which allowed us to recognize the replication competency of ERV-
DC14. Additionally, we observed ERV-DC14 virions using TEM.
The essential attributes of ERV-DC14 match those of a type C
retrovirus. This type of virus is morphologically similar to gam-
maretroviruses, such as ERV-DC10 and ERV-DC18, and has
characteristic core, envelope, and virus budding (28). Thus, ERV-
DC14 is an authentic replication-competent provirus residing
within the feline genome.
ERV-DCs are divided into three genotypes: genotype I includes
ERV-DC14, genotype III includes ERV-DC10/DC18, and geno-
type II includes ERV-DC7 and ERV-DC16, both of which encode
Refrex-1, a known viral restriction factor. In addition to phylog-
eny, replication activity, and promoter activity, the ERV-DC14
receptor usage is distinct from that of ERV-DC10/DC18, as deter-
mined by the results of viral interference assays (29). In this study,
FIG 8 Viral properties of ERV-DC14 and of the ERV-DC14TA mutant. (A) ERV-DC14TA, which contains substitutions of T to A at positions 281 and 8598 in
the 5= and 3= LTRs, respectively, of ERV-DC14, was constructed. (B) 293Lac cells were transfected with ERV-DC14, ERV-DC14TA, or ERV-DC10 or were mock
transfected, and the resulting supernatants were collected and used to infect HEK293T cells. (Top) Cells were fixed at 48 h postinfection and visualized by X-Gal
staining. (Bottom) Viral titers are expressed in IU per milliliter. nd, not detected. The results were collected from at least six independent experiments with
ERV-DC14 (n 	 6), ERV-DC14TA (n 	 7), and ERV-DC10 (n 	 7). Pictures from one of them are shown. The results were statistically analyzed by one-way
analysis of variance (*, P  0.05). (C) The expression levels of pol, env, and -actin mRNAs in HEK293T cells 2 days after mock infection or infection with
ERV-DC14 or ERV-DC14TA were assessed by RT-PCR. (D) Growth kinetics of ERV-DCs. 293Lac cells were transfected with equal amounts of ERV-DC14,
ERV-DC14TA, or ERV-DC10. To monitor viral growth, culture supernatants were collected periodically after transfection as indicated, and viruses filtered
through a 0.45-m filter were used to inoculate HEK293T cells. The resulting viral titers were determined by X-Gal staining.
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we determined the infectious tropism of ERV-DC14 and ERV-
DC10; in the absence of Refrex-1, ERV-DC14 broadly infects sev-
eral species, including cats, while ERV-DC10 exhibits more lim-
ited infection. In other words, the infectivity of ERV-DC14 is
nonecotropic, whereas that of ERV-DC10/DC18 appears to be
xenotropic.
As described above, two distinct types of infectious ERVs reside
within the feline genome, ERV-DC10/DC18 and ERV-DC14.
They differ in their phylogenies, receptor usages, and transcrip-
tional activities. Additionally, the feline genome also contains do-
mesticated (noninfectious) ERV-DCs, such as ERV-DC7 and
ERV-DC16. We were interested in which mechanisms the host
uses to control these ERVs with distinctly different properties, so
we investigated their transcriptional regulations.
First, we examined ERV-DC transcription in feline tissues. Al-
though RD-114 feline ERV is expressed in both normal and ma-
lignant tissues in domestic cats (64, 65), the RT-PCR assays that
we used to detect ERV-DCs cannot detect this ERV. Qualitative
and quantitative analyses demonstrated that env genes corre-
sponding to ERV-DC genotypes I, II, and III were expressed in
feline tissues. All three genotypes were relatively well expressed in
hematopoietic tissues such as blood, spleen, and thymus tissues.
Genotype II, which includes Refrex-1, was dominantly expressed
across broad tissue types, in agreement with data from our previ-
ous study (29). Genotype I was also expressed in feline tissues.
This is consistent with the observation that FeLV-D is generated
by the transduction of the ERV-DC genotype I env gene (29)
through a template switch during reverse transcription (66). Ge-
notype III had a lower level of expression than the others, even
though this group includes ERV-DC10, which can replicate to
high levels in cultured cells. These findings agree with our previ-
ous observation that ERV-DC production was not detected in the
tested domestic cat PBMCs (28). However, this study did not de-
termine whether or not ERV-DC14 is expressed in vivo. Owing to
the very low frequency of ERV-DC14 provirus in cats, it is difficult
to obtain RNA samples with ERV-DC14.
Second, we examined the CpG methylation status of the 5=
LTRs for each ERV-DC locus by performing a sodium bisulfite
sequence analysis on blood from healthy cats. The CpG methyl-
ation of an LTR generally suppresses its viral promoter activity,
and we confirmed that this trend also applies to ERV-DC LTRs
(Fig. 7). The 5= LTRs of ERV-DC10/DC18, which belong to geno-
type III, were hypermethylated (84 to 98%), whereas ERV-DC7
and ERV-DC16, which belong to genotype II, were hypomethy-
lated (0 and 17%, respectively). These results agree with the low
and high expression levels of genotype III and genotype II, respec-
tively, in blood tissues. In cells persistently infected with titers of at
least 104 IU/ml of ERV-DC10 or ERV-DC18, the viruses exhibited
hypomethylation in their LTRs. The methylation state of ERV-
DC7 may be affected by genome imprinting, because this provirus
is located on feline chromosome X, and we used a female sample
for this analysis. The LTRs of genotype I ERV-DCs, which are
expressed at medium levels in some tissues, had correspondingly
medium levels of methylation (23 to 47%). Interestingly, the
methylation in the LTRs of genotype I specifically occurs down-
stream of the TATA box, indicating the importance of the meth-
ylation level in the transcriptional initiation region. In summary,
the methylation levels of LTRs are different among ERV-DC loci,
and these patterns are correlated with their genotypes. One of the
TABLE 4 ERV-DC10 and ERV-DC14 tropismsa
Species Cell line
Mean viral titer (IU/ml) 
 SD
ERV-DC14TA ERV-DC10
Human HepG2 (2.1 
 0.1)  104 (1.1 
 0.0)  104
HeLa (1.0 
 0.1)  104 (7.4 
 0.0)  103
HEK293T (1.1 
 0.2)  104 (4.4 
 0.5)  104
MCF7 (9.0 
 1.4)  102 6.7 
 2.9
Cat AH927 (3.8 
 0.9)  103 0
CRFK (4.4 
 1.7)  103 (5.6 
 2.5)  101
Monkey Vero (6.0 
 2.5)  102 (1.4 
 1.0)  101
Cos7 (3.3 
 0.7)  103 2.0 
 1.4
Mouse NIH 3T3 0 0
MDTF 0 0
Hamster BHK21 0 0
Guinea pig 104C1 (1.7 
 0.7)  103 0
Dog KwDM (1.8 
 0.3)  104 (1.4 
 0.1)  104
Cow MDBK (5.3 
 1.9)  103 0
a Human, monkey, feline, canine, bovine, murine, hamster, and guinea pig cells were
infected with the viruses generated by the transfection of viral molecular clones of ERV-
DC14TA or ERV-DC10 into 293Lac cells. At 2 days posttransfection, LacZ-positive cells
were quantified microscopically. These results are representative of data from at least
three independent experiments.
FIG 9 ERV-DC14 and ERV-DC14TA mutant virions. Shown are representa-
tive images from TEM of retroviral particles in HEK293T cells that were trans-
fected with molecular clones of ERV-DC14 (A and B) or ERV-DC14TA (C to
E). Bars, 100 nm.
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FIG 10 ERV-DC invasion of the cat genome. (A) The single nucleotide polymorphism of either A or T in the cis element within ERV-DC LTRs was termed either
an A-type LTR, which confers higher-level promoter activity, or a T-type LTR, which confers lower-level promoter activity. (B) ERV-DC LTRs were extracted
from the UCSC feline genome database. A phylogenetic tree with 92 of these ERV-DC LTRs was constructed from an in silico analysis using the maximum
likelihood method, and its robustness was evaluated by bootstrapping (1,000 times). The results were separated into genotypes I (68 LTRs), II (6 LTRs), and III
(18 LTRs). (C) The ratio of each group, genotype I with T-type LTRs, genotype I with A-type LTRs, genotype II, and genotype III, is represented in a pie chart.
A chi-squared test was conducted to assess the statistical significance of these results.
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major functions of DNA methylation is thought to be the silencing
of ERVs (67–69), and ERV demethylation and expression cause an
immune response (69, 70). A similar phenomenon may occur in
the association with ERV-DC gene regulation. In this experiment,
5= LTRs were investigated for their methylation status because 5=
LTRs, but not 3= LTRs, are thought to be promoters for ERV-DCs.
However, it would be interesting to analyze further elements, in-
cluding 3= LTRs, to determine the region-specific methylation
within ERVs.
The key finding of this study is that the basal promoter activity
of ERV-DC LTRs can be classified into two groups, A-type LTRs
and T-type LTRs, according to the nucleotide present at position
281 in the ERV-DC14 LTR. A-type LTRs exhibit high levels of
promoter activity, while T-type LTRs exhibit low or attenuated
levels of promoter activity (no promoter activity detected in the
reporter assay) (Fig. 6). Although promoter activities of T-type
LTRs are attenuated, they appear to retain a minimum level of
activity for productive viral replication based on the observed
ERV-DC14 replication capacity and the expansion of T-type LTRs
in the host genome. This is supported by our detection of T-type
LTR genotype I ERV-DC expression in feline tissues (Fig. 3A). The
T-type LTRs are commonly observed in a certain clade of
ERV-DC genotype I. Given that genotype II is the oldest subgroup
of ERV-DCs, T-type LTRs were likely generated from A-type
LTRs through a preintegration substitution that occurred during
the genomic invasion of genotype I.
Interestingly, RD-114, a virus with a high level of sequence
similarity to ERV-DCs in its LTRs, has an A-type LTR. Further-
more, the region that includes the nucleotide corresponding to the
281st nucleotide of ERV-DC14 duplicated and formed direct re-
peats in RD-114 LTRs (71, 72). Previous studies also showed that
this repeated region functions as a viral enhancer in the RD-114
virus (71, 72). Together with those results, our findings suggest
that that A-type LTRs of ERV-DCs and RD-114 have a transcrip-
tional cis element that enhances viral replication in this region and
that T-type LTRs were generated from A-type LTRs through a
disruption of their cis elements caused by an A-to-T substitution.
Our in silico analysis shows that the proportion of T-type LTRs
is significantly higher in both the genotype I population and the
total ERV-DC population (Fig. 10C). In other words, ERV-DCs
with T-type LTRs have invaded the feline genome significantly
more than other populations have, despite their low level of pro-
moter activity. We hypothesize that this observation reflects a viral
strategy for succeeding in endogenization: ERV-DCs with T-type
LTRs appear to have attenuated their promoter activities in order
to escape from strong suppressions or negative selections by the
host. In fact, the 5= LTR of ERV-DC14 refrains from severe meth-
ylation in blood cells, although this virus retains a minimal repli-
cation capacity. Thus, we consider that disruption of the cis ele-
ment in the LTR and reduction of its promoter activity led to the
preferential invasion of ERV-DCs with T-type LTRs in the host
genome.
This study revealed the presence of two distinct types of infec-
tious ERVs residing within the cat genome as well as how the hosts
control these potentially infectious proviruses. Infectious ERV-
DCs are regulated by two mechanisms: methylation of the pro-
moter and mutation of the promoter. ERV-DC10 and ERV-DC18
expression levels are regulated by promoter methylation, while the
ERV-DC14 expression level is low due to the attenuation of its
promoter caused by a mutation in its LTR. Furthermore, the do-
mesticated ERVs ERV-DC7 and ERV-DC16 are highly expressed
in tissues, and they are regulated by a different mechanism than
either of those used to control infectious ERVs; these domesti-
cated ERVs retain the strongest promoter activity and the lowest
methylation levels among ERV-DCs. In summary, various types
of ERV-DCs are present in the host feline genome, and they are
controlled via several different mechanisms. These different ways
of controlling ERVs seem to have been formed through host-virus
conflict.
In conclusion, our results provide insights into how the host
controls potentially infectious ERVs and, conversely, how ERVs
adapt to and invade the host genome. Thus, cats provide a unique
system for studying these mechanisms in field animals. Studying
these ancestral infectious viruses might uncover previously unrec-
ognized features or properties of retroviruses.
ACKNOWLEDGMENTS
We are grateful to Kunio Nagashima (Leidos Biomedical Research, Inc.)
and Alan Rein (National Cancer Institute-Frederick) for their helpful sug-
gestions.
FUNDING INFORMATION
This work, including the efforts of Kazuo Nishigaki, was funded by Japan
Society for the Promotion of Science (JSPS) (KAKENHI 15H04602).
REFERENCES
1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J,
Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K,
Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P,
McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J,
Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-
Thomann Y, Stojanovic N, Subramanian A, Wyman D, Rogers J,
Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N,
Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R,
French L, Grafham D, et al. 2001. Initial sequencing and analysis of the
human genome. Nature 409:860 –921. http://dx.doi.org/10.1038
/35057062.
2. Mouse Genome Sequencing Consortium, Waterston RH, Lindblad-Toh
K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R,
Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey
J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M,
Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J,
Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT,
Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR,
Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R,
Davies J, Delehaunty KD, Deri J, et al. 2002. Initial sequencing and
comparative analysis of the mouse genome. Nature 420:520 –562. http:
//dx.doi.org/10.1038/nature01262.
3. Herniou E, Martin J, Miller K, Cook J, Wilkinson M, Tristem M. 1998.
Retroviral diversity and distribution in vertebrates. J Virol 72:5955–5966.
4. Coffin JM. 2004. Evolution of retroviruses: fossils in our DNA. Proc Am
Philos Soc 148:264 –280.
5. Stoye JP. 2012. Studies of endogenous retroviruses reveal a continuing
evolutionary saga. Nat Rev Microbiol 10:395– 406. http://dx.doi.org/10
.1038/nrmicro2783.
6. Weiss RA. 2006. The discovery of endogenous retroviruses. Retrovirology
3:67. http://dx.doi.org/10.1186/1742-4690-3-67.
7. Kozak CA. 2015. Origins of the endogenous and infectious laboratory
mouse gammaretroviruses. Viruses 7:1–26. http://dx.doi.org/10.3390
/v7010001.
8. Hanger JJ, Bromham LD, McKee JJ, O’Brien TM, Robinson WF. 2000.
The nucleotide sequence of koala (Phascolarctos cinereus) retrovirus: a
novel type C endogenous virus related to gibbon ape leukemia virus. J
Virol 74:4264 – 4272. http://dx.doi.org/10.1128/JVI.74.9.4264-4272.2000.
9. Tarlinton RE, Meers J, Young PR. 2006. Retroviral invasion of the koala
genome. Nature 442:79 – 81. http://dx.doi.org/10.1038/nature04841.
10. Armstrong JA, Porterfield JS, De Madrid AT. 1971. C-type virus parti-
Transcriptional Regulation of Infectious Feline ERVs
October 2016 Volume 90 Number 20 jvi.asm.org 9043Journal of Virology
cles in pig kidney cell lines. J Gen Virol 10:195–198. http://dx.doi.org/10
.1099/0022-1317-10-2-195.
11. Todaro GJ, Benveniste RE, Lieber MM, Sherr CJ. 1974. Characterization
of a type C virus released from the porcine cell line PK(15). Virology
58:65–74. http://dx.doi.org/10.1016/0042-6822(74)90141-X.
12. Moennig V, Frank H, Hunsmann G, Ohms P, Schwarz H, Schafer W.
1974. C-type particles produced by a permanent cell line from a leukemic
pig. II. Physical, chemical, and serological characterization of the particles.
Virology 57:179 –188.
13. Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. 1998.
Type C retrovirus released from porcine primary peripheral blood mono-
nuclear cells infects human cells. J Virol 72:3082–3087.
14. Le Tissier P, Stoye JP, Takeuchi Y, Patience C, Weiss RA. 1997. Two sets
of human-tropic pig retrovirus. Nature 389:681– 682. http://dx.doi.org/10
.1038/39489.
15. Aaronson SA, Tronick SR, Stephenson JR. 1976. Endogenous type C RNA
virus of Odocoileus hemionus, a mammalian species of New World origin.
Cell 9:489–494. http://dx.doi.org/10.1016/0092-8674(76)90094-5.
16. Fabryova H, Hron T, Kabickova H, Poss M, Elleder D. 2015. Induction
and characterization of a replication competent cervid endogenous gam-
maretrovirus (CrERV) from mule deer cells. Virology 485:96 –103. http:
//dx.doi.org/10.1016/j.virol.2015.07.003.
17. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung
HJ, Tepper CG, Hu WS, Fivash MJ, Jr, Coffin JM, Pathak VK. 2011.
Recombinant origin of the retrovirus XMRV. Science 333:97–101. http:
//dx.doi.org/10.1126/science.1205292.
18. Young GR, Eksmond U, Salcedo R, Alexopoulou L, Stoye JP, Kassiotis
G. 2012. Resurrection of endogenous retroviruses in antibody-deficient
mice. Nature 491:774 –778. http://dx.doi.org/10.1038/nature11599.
19. Yu P, Lubben W, Slomka H, Gebler J, Konert M, Cai C, Neubrandt L,
Prazeres da Costa O, Paul S, Dehnert S, Dohne K, Thanisch M,
Storsberg S, Wiegand L, Kaufmann A, Nain M, Quintanilla-Martinez L,
Bettio S, Schnierle B, Kolesnikova L, Becker S, Schnare M, Bauer S.
2012. Nucleic acid-sensing Toll-like receptors are essential for the control
of endogenous retrovirus viremia and ERV-induced tumors. Immunity
37:867– 879. http://dx.doi.org/10.1016/j.immuni.2012.07.018.
20. Triviai I, Ziegler M, Bergholz U, Oler AJ, Stubig T, Prassolov V, Fehse
B, Kozak CA, Kroger N, Stocking C. 2014. Endogenous retrovirus in-
duces leukemia in a xenograft mouse model for primary myelofibrosis.
Proc Natl Acad Sci U S A 111:8595– 8600. http://dx.doi.org/10.1073/pnas
.1401215111.
21. David VA, Menotti-Raymond M, Wallace AC, Roelke M, Kehler J,
Leighty R, Eizirik E, Hannah SS, Nelson G, Schaffer AA, Connelly CJ,
O’Brien SJ, Ryugo DK. 2014. Endogenous retrovirus insertion in the KIT
oncogene determines white and white spotting in domestic cats. G3 (Be-
thesda) 4:1881–1891. http://dx.doi.org/10.1534/g3.114.013425.
22. Jenkins NA, Copeland NG, Taylor BA, Lee BK. 1981. Dilute (d) coat
colour mutation of DBA/2J mice is associated with the site of integration
of an ecotropic MuLV genome. Nature 293:370 –374. http://dx.doi.org/10
.1038/293370a0.
23. Rabson AB, Graves BJ. 1997. Synthesis and processing of viral RNA. In
Coffin JM, Hughes SH, Varmus HE (ed), Retroviruses. Cold Spring Har-
bor Laboratory Press, Cold Spring Harbor, NY.
24. Robbez-Masson L, Rowe HM. 2015. Retrotransposons shape species-
specific embryonic stem cell gene expression. Retrovirology 12:45. http:
//dx.doi.org/10.1186/s12977-015-0173-5.
25. Slotkin RK, Martienssen R. 2007. Transposable elements and the epige-
netic regulation of the genome. Nat Rev Genet 8:272–285. http://dx.doi
.org/10.1038/nrg2072.
26. Beyer W, Mohring R, Drescher B, Notzel U, Rosenthal S. 1987. Molec-
ular cloning of an endogenous cat retroviral element (ECE 1)—a recom-
binant between RD-114 and FeLV-related sequences. Brief report. Arch
Virol 96:297–301. http://dx.doi.org/10.1007/BF01320971.
27. van der Kuyl AC, Dekker JT, Goudsmit J. 1999. Discovery of a new
endogenous type C retrovirus (FcEV) in cats: evidence for RD-114 being
an FcEV(Gag-Pol)/baboon endogenous virus BaEV(Env) recombinant. J
Virol 73:7994 – 8002.
28. Anai Y, Ochi H, Watanabe S, Nakagawa S, Kawamura M, Gojobori T,
Nishigaki K. 2012. Infectious endogenous retroviruses in cats and emer-
gence of recombinant viruses. J Virol 86:8634 – 8644. http://dx.doi.org/10
.1128/JVI.00280-12.
29. Ito J, Watanabe S, Hiratsuka T, Kuse K, Odahara Y, Ochi H, Kawamura
M, Nishigaki K. 2013. Refrex-1, a soluble restriction factor against feline
endogenous and exogenous retroviruses. J Virol 87:12029 –12040. http:
//dx.doi.org/10.1128/JVI.01267-13.
30. Lavialle C, Cornelis G, Dupressoir A, Esnault C, Heidmann O, Verno-
chet C, Heidmann T. 2013. Paleovirology of ‘syncytins’, retroviral env
genes exapted for a role in placentation. Philos Trans R Soc Lond B Biol
Sci. 368:20120507. http://dx.doi.org/10.1098/rstb.2012.0507.
31. Malfavon-Borja R, Feschotte C. 2015. Fighting fire with fire: endogenous
retrovirus envelopes as restriction factors. J Virol 89:4047– 4050. http://dx
.doi.org/10.1128/JVI.03653-14.
32. Ito J, Baba T, Kawasaki J, Nishigaki K. 2016. Ancestral mutations
acquired in Refrex-1, a restriction factor against feline retroviruses, during
its cooption and domestication. J Virol 90:1470 –1485. http://dx.doi.org
/10.1128/jvi.01904-15.
33. Arnaud F, Caporale M, Varela M, Biek R, Chessa B, Alberti A, Golder
M, Mura M, Zhang YP, Yu L, Pereira F, Demartini JC, Leymaster K,
Spencer TE, Palmarini M. 2007. A paradigm for virus-host coevolution:
sequential counter-adaptations between endogenous and exogenous ret-
roviruses. PLoS Pathog 3:e170. http://dx.doi.org/10.1371/journal.ppat
.0030170.
34. Best S, Le Tissier P, Towers G, Stoye JP. 1996. Positional cloning of the
mouse retrovirus restriction gene Fv1. Nature 382:826 – 829. http://dx.doi
.org/10.1038/382826a0.
35. Ikeda H, Sugimura H. 1989. Fv-4 resistance gene: a truncated endoge-
nous murine leukemia virus with ecotropic interference properties. J Virol
63:5405–5412.
36. Jung YT, Lyu MS, Buckler-White A, Kozak CA. 2002. Characterization
of a polytropic murine leukemia virus proviral sequence associated with
the virus resistance gene Rmcf of DBA/2 mice. J Virol 76:8218 – 8224. http:
//dx.doi.org/10.1128/JVI.76.16.8218-8224.2002.
37. Wu T, Yan Y, Kozak CA. 2005. Rmcf2, a xenotropic provirus in the Asian
mouse species Mus castaneus, blocks infection by polytropic mouse gam-
maretroviruses. J Virol 79:9677–9684. http://dx.doi.org/10.1128/JVI.79
.15.9677-9684.2005.
38. Mura M, Murcia P, Caporale M, Spencer TE, Nagashima K, Rein A,
Palmarini M. 2004. Late viral interference induced by transdominant Gag
of an endogenous retrovirus. Proc Natl Acad Sci U S A 101:11117–11122.
http://dx.doi.org/10.1073/pnas.0402877101.
39. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. 1979. Con-
trolled synthesis of HBsAg in a differentiated human liver carcinoma-
derived cell line. Nature 282:615– 616. http://dx.doi.org/10.1038
/282615a0.
40. Gey GO, Coffman MT, Kubicek WD. 1952. Tissue culture studies of the
proliferative capacity of cervical carcinoma and normal epithelium. Can-
cer Res 12:264 –265.
41. Soule HD, Vazguez J, Long A, Albert S, Brennan M. 1973. A human cell
line from a pleural effusion derived from a breast carcinoma. J Natl Cancer
Inst 51:1409 –1416.
42. Gluzman Y. 1981. SV40-transformed simian cells support the replication
of early SV40 mutants. Cell 23:175–182. http://dx.doi.org/10.1016/0092
-8674(81)90282-8.
43. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. 1987.
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle
system. Mol Cell Biol 7:379 –387. http://dx.doi.org/10.1128/MCB.7.1.379.
44. Rasheed S, Gardner MB. 1980. Characterization of cat cell cultures for
expression of retrovirus, FOCMA and endogenous sarc genes, p 393– 400.
In Hardy WD, Jr, Essex M, McClelland AJ (ed), Proceedings of the Third
International Feline Leukemia Virus Meeting. Elsevier, North-Holland
Publishing Co, New York, NY.
45. Haapala DK, Robey WG, Oroszlan SD, Tsai WP. 1985. Isolation from
cats of an endogenous type C virus with a novel envelope glycoprotein. J
Virol 53:827– 833.
46. Bassin RH, Ruscetti S, Ali I, Haapala DK, Rein A. 1982. Normal DBA/2
mouse cells synthesize a glycoprotein which interferes with MCF virus
infection. Virology 123:139 –151. http://dx.doi.org/10.1016/0042-6822
(82)90301-4.
47. Crandell RA, Fabricant CG, Nelson-Rees WA. 1973. Development,
characterization, and viral susceptibility of a feline (Felis catus) renal cell
line (CRFK). In Vitro 9:176 –185. http://dx.doi.org/10.1007/BF02618435.
48. Jainchill JL, Aaronson SA, Todaro GJ. 1969. Murine sarcoma and leu-
kemia viruses: assay using clonal lines of contact-inhibited mouse cells. J
Virol 4:549 –553.
49. Yasumura Y, Kawakita Y. 1963. Studies on SV40 virus in tissue culture
cells. Nippon Rinsho 21:1201–1215.
Kuse et al.
9044 jvi.asm.org October 2016 Volume 90 Number 20Journal of Virology
50. Macpherson I, Stoker M. 1962. Polyoma transformation of hamster cell
clones—an investigation of genetic factors affecting cell competence. Vi-
rology 16:147–151. http://dx.doi.org/10.1016/0042-6822(62)90290-8.
51. Lander MR, Chattopadhyay SK. 1984. A Mus dunni cell line that lacks
sequences closely related to endogenous murine leukemia viruses and can
be infected by ectropic, amphotropic, xenotropic, and mink cell focus-
forming viruses. J Virol 52:695– 698.
52. Evans CH, DiPaolo JA. 1975. Neoplastic transformation of guinea pig
fetal cells in culture induced by chemical carcinogens. Cancer Res 35:
1035–1044.
53. Madin SH, Darby NB, Jr. 1958. Established kidney cell lines of normal
adult bovine and ovine origin. Proc Soc Exp Biol Med 98:574 –576. http:
//dx.doi.org/10.3181/00379727-98-24111.
54. Miyake A, Watanabe S, Hiratsuka T, Ito J, Ngo MH, Makundi I,
Kawasaki J, Endo Y, Tsujimoto H, Nishigaki K. 2016. Novel feline
leukemia virus interference group based on env gene. J Virol 90:4832–
4837. http://dx.doi.org/10.1128/JVI.03229-15.
55. Cornelis G, Heidmann O, Bernard-Stoecklin S, Reynaud K, Veron G,
Mulot B, Dupressoir A, Heidmann T. 2012. Ancestral capture of syncy-
tin-Car1, a fusogenic endogenous retroviral envelope gene involved in
placentation and conserved in Carnivora. Proc Natl Acad Sci U S A 109:
E432–E441. http://dx.doi.org/10.1073/pnas.1115346109.
56. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accu-
racy and high throughput. Nucleic Acids Res 32:1792–1797. http://dx.doi
.org/10.1093/nar/gkh340.
57. Kimura M. 1980. A simple method for estimating evolutionary rates of
base substitutions through comparative studies of nucleotide sequences. J
Mol Evol 16:111–120. http://dx.doi.org/10.1007/BF01731581.
58. Schwarz G. 1978. Estimating the dimension of a model. Ann Stat 6:461–
464. http://dx.doi.org/10.1214/aos/1176344136.
59. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6:
Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 30:
2725–2729. http://dx.doi.org/10.1093/molbev/mst197.
60. Roca AL, Pecon-Slattery J, O’Brien SJ. 2004. Genomically intact endog-
enous feline leukemia viruses of recent origin. J Virol 78:4370 – 4375. http:
//dx.doi.org/10.1128/JVI.78.8.4370-4375.2004.
61. Shimode S, Nakagawa S, Miyazawa T. 2015. Multiple invasions of an
infectious retrovirus in cat genomes. Sci Rep 5:8164. http://dx.doi.org/10
.1038/srep08164.
62. Delviks-Frankenberry K, Paprotka T, Cingoz O, Wildt S, Hu WS,
Coffin JM, Pathak VK. 2013. Generation of multiple replication-
competent retroviruses through recombination between PreXMRV-1 and
PreXMRV-2. J Virol 87:11525–11537. http://dx.doi.org/10.1128/JVI
.01787-13.
63. Kearney MF, Lee K, Bagni RK, Wiegand A, Spindler J, Maldarelli F,
Pinto PA, Linehan WM, Vocke CD, Delviks-Frankenberry KA, Devere
White RW, Del Prete GQ, Mellors JW, Lifson JD, Kewalramani VN,
Pathak VK, Coffin JM, Le Grice SF. 2011. Nucleic acid, antibody, and
virus culture methods to detect xenotropic MLV-related virus in human
blood samples. Adv Virol 2011:272193. http://dx.doi.org/10.1155/2011
/272193.
64. Niman HL, Stephenson JR, Gardner MB, Roy-Burman P. 1977. RD-114
and feline leukemia virus genome expression in natural lymphomas of
domestic cats. Nature 266:357–360. http://dx.doi.org/10.1038/266357a0.
65. Niman HL, Gardner MB, Stephenson JR, Roy-Burman P. 1977. Endog-
enous RD-114 virus genome expression in malignant tissues of domestic
cats. J Virol 23:578 –586.
66. Hu WS, Temin HM. 1990. Retroviral recombination and reverse transcrip-
tion. Science 250:1227–1233. http://dx.doi.org/10.1126/science.1700865.
67. Walsh CP, Chaillet JR, Bestor TH. 1998. Transcription of IAP endoge-
nous retroviruses is constrained by cytosine methylation. Nat Genet 20:
116 –117. http://dx.doi.org/10.1038/2413.
68. Bestor TH, Tycko B. 1996. Creation of genomic methylation patterns.
Nat Genet 12:363–367. http://dx.doi.org/10.1038/ng0496-363.
69. Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B,
Hein A, Rote NS, Cope LM, Snyder A, Makarov V, Buhu S, Slamon DJ,
Wolchok JD, Pardoll DM, Beckmann MW, Zahnow CA, Mergoub T,
Chan TA, Baylin SB, Strick R. 2015. Inhibiting DNA methylation causes
an interferon response in cancer via dsRNA including endogenous retro-
viruses. Cell 162:974 –986. http://dx.doi.org/10.1016/j.cell.2015.07.011.
70. Hurst TP, Magiorkinis G. 2015. Activation of the innate immune re-
sponse by endogenous retroviruses. J Gen Virol 96:1207–1218. http://dx
.doi.org/10.1099/jgv.0.000017.
71. Spodick DA, Ghosh AK, Parimoo S, Roy-Burman P. 1988. The long
terminal repeat of feline endogenous RD-114 retroviral DNAs: analysis of
transcription regulatory activity and nucleotide sequence. Virus Res
9:263–283. http://dx.doi.org/10.1016/0168-1702(88)90035-4.
72. Ghosh AK, Roy-Burman P. 1989. Characterization of enhancer elements
and their mutations in the long terminal repeat of feline endogenous RD-
114 proviruses. J Virol 63:4234 – 4241.
73. Science Council of Japan. 2006. Guidelines for proper conduct of animal
experiments. Science Council of Japan, Tokyo, Japan. http://www.scj.go
.jp/ja/info/kohyo/pdf/kohyo-20-k16-2e.pdf.
Transcriptional Regulation of Infectious Feline ERVs
October 2016 Volume 90 Number 20 jvi.asm.org 9045Journal of Virology
